Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Newly developed simple QoL questionnaire in early detection of COPD in a population of smokers at risk for COPD development (CROSBI ID 591361)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Radoševic-Vidaček, Biserka ; Košćec, Adrijana ; Vrbica, Žarko ; Gudelj, Ivan ; Rosandić-Piasevoli, Rosanda ; Tudja, Karla ; Meštrović, Zdenka ; Martinkovič, Davorka ; Plavec, Davor Newly developed simple QoL questionnaire in early detection of COPD in a population of smokers at risk for COPD development // The European respiratory journal. 2012. str. P3968-731s-P3968-731s

Podaci o odgovornosti

Radoševic-Vidaček, Biserka ; Košćec, Adrijana ; Vrbica, Žarko ; Gudelj, Ivan ; Rosandić-Piasevoli, Rosanda ; Tudja, Karla ; Meštrović, Zdenka ; Martinkovič, Davorka ; Plavec, Davor

engleski

Newly developed simple QoL questionnaire in early detection of COPD in a population of smokers at risk for COPD development

Aim: Assessing the role of a simple newly developed QoL questionnaire (MARKOQ) in early detection of COPD in a population at risk for COPD. Methods: MARKOQ is a self-administered questionnaire with 18 questions. Subjects were smokers with ≥20 pack-years, both gender, 40-65 yrs of age, with no diagnosis of COPD. They were referred to a pulmologist (history, physical, lung function) for diagnosis of COPD and the staging. MARKOQ was administered twice: at primary care clinic and 2-4 weeks later at a pulmology clinic. Results: Sample included 219 consecutive subjects (48.5% male), mean (SD) age 52.6 (6.9) yrs with 38.0 (17.4) pack-years. 25.3% were diagnosed as COPD (stage I 18%, stage II 6.7%, stage III 0.6%). Psychometric analyses showed very good internal consistency of MARKOQ (Cronbach’s alpha=0.89) and test-retest reliability (r=0.84). The correlation with CAT scores was r=0.54. MARKOQ significantly discriminated (F=4.20, p=0.013) patients with GOLD stage II or higher (mean=19.9, SD=8.7) from those in stage I (mean=12.9, SD=10.1) and “healthy” smokers (mean=12.9, SD=8.4) (CAT scores were not discriminative). Correlations of MARKOQ scores were only significant for FEV1%, (r=-0.22, p=0.003). Conclusions: Our results indicate that the MARKOQ developed for an early detection of COPD may be able to detect early changes in QoL complementary to lung function impairment. The exact validity of the MARKOQ will be known after the reevaluation based on the cohort follow-up.

Psychometric properties ; Quality of life ; COPD

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

P3968-731s-P3968-731s.

2012.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

The European respiratory journal

0903-1936

Podaci o skupu

22nd Annula Congress of the European Respiratory Society

poster

01.09.2012-05.09.2012

Beč, Austrija

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Psihologija

Indeksiranost